(Q33198902)

English

A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Plasmodium falciparum

0 references

1 reference

based on heuristic

inferred from title

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

object named as

Frank Follmann

4

0 references

8

object named as

Pierre Druilhe

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

2

object named as

Soe Soe

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Michael Theisen

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Katja Brunstedt

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Lars Bredmose

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Hans Israelsen

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Søren M Madsen

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

9-10

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1188-1198

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Naturally acquired antibodies to the glutamate-rich protein are associated with protection against plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Cloning, nucleotide sequencing and analysis of the gene encoding the glutamate-rich protein (GLURP) from Plasmodium reichenowi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Characterization of a novel plasmid-encoded HsdS subunit, S.LlaW12I, from Lactococcus lactis W12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Characterization of purified protein derivative of tuberculin by use of monoclonal antibodies: isolation of a delayed-type hypersensitivity reactive component from M. tuberculosis culture filtrate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Matrix-assisted laser desorption/ionization mass spectrometric peptide mapping of the neural cell adhesion protein neurolin purified by sodium dodecyl sulfate polyacrylamide gel electrophoresis or acidic precipitation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Controlled production of stable heterologous proteins in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

Fc receptors and immunity to parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal Requirements for Exponential Growth of Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.09.017

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33198902&oldid=1946925687"